+1 (202) 780-3397
Mini Review - Allied Journal of Medical Research (2023) Volume 7, Issue 2
Transforming Healthcare: The Power of Translational Medicine
Michal Yuan *
Department of Pharmacodynamics, Medical University of Warsaw, Warszawa, Poland
- *Corresponding Author:
- Michal Yuan
Department of Pharmacodynamics,
Medical University of Warsaw,
Warszawa, Poland
E-mail: Yuan.m@wum.edu.pl
Received: 03-Jan-2023, Manuscript No. AAAJMR-23-88474; Editor assigned: 05-Jan-2023, PreQC No. AAAJMR-23-88474(PQ); Reviewed: 20-Jan-2023, QC No. AAAJMR-23-88474; Revised: 27-Jan-2023, Manuscript No. AAAJMR-23-88474; Published: 03-Feb-2023, DOI:10.35841/aaajmr-7.2.167
Citation: Yuan M. Transforming healthcare: The power of translational medicine. Allied J Med Res. 2023;7(2):167
Abstract
Translational medicine has the potential to revolutionize the healthcare industry. It is an interdisciplinary field that aims to bring together basic scientific research and clinical practice to improve human health. The ultimate goal of translational medicine is to translate laboratory findings into practical treatments and cures for patients. In this article, we will explore the power of translational medicine and its potential to transform the healthcare industry
Keywords
Translational medicine, Healthcare industry, Biomarkers, Pharmacogenomics.
Introduction
Translational medicine involves a continuous cycle of discovery, development, and delivery. It starts with basic scientific research in the laboratory, where scientists work to understand the underlying mechanisms of disease. This knowledge is then translated into practical treatments and therapies, which are tested and refined in clinical trials. If successful, these treatments can be delivered to patients in the form of drugs, devices, or procedures [1].
One of the key strengths of translational medicine is its ability to bring together the best of both worlds: the knowledge and expertise of basic science researchers and the practical experience and insights of healthcare practitioners. This collaboration ensures that scientific discoveries are translated into practical treatments that are both effective and safe for patients. Biomarkers are medical measurements, such as physiological measurements, blood tests, molecular analyses of biopsies, genetic or metabolic data, and measurements from photographs. The phrase "advancing clinical research and applications" highlighted this point. Biomarkers are experiencing a revival due to growing interest. They act as the "glue" that holds many of the component translational fields together [2].
Translational medicine also offers the potential for personalized medicine, which tailors treatments to the specific needs of individual patients. With advances in genetic and genomic research, it is now possible to identify the specific genetic mutations that cause a particular disease, and develop treatments that target these mutations directly. This approach is particularly promising in the treatment of cancer, where treatments can be tailored to the specific genetic mutations present in each patient's tumor [3].
Often referred to be the face of translational medicine, pharmacogenomics. Pharmacogenomics, which is defined as the "study of variations in DNA sequences as related to drug response" by the International Conference of Harmonization, has long been acknowledged for its contribution to interindividual variability in drug response and toxicity, and an increasing number of drug labels now include suggestions for genotype-guided dosing of therapeutics [4].
A broader definition of pharmacogenomics research that includes genes and pathways that underpin the pharmacologic and toxic response to medicines has replaced the conventional emphasis on uncovering genetic determinants of drug exposure (pharmacokinetics) in recent years. Another important aspect of translational medicine is its ability to speed up the development of new treatments. In the traditional model of drug development, it can take years or even decades to bring a new drug to market. Translational medicine, on the other hand, has the potential to shorten this time frame by allowing researchers to test new treatments in the laboratory, and then quickly move them into clinical trials. This can help to get new treatments to patients more quickly, and can save lives in the process [5].
Conclusion
In conclusion, translational medicine has the potential to transform the healthcare industry, by bringing together basic science research and clinical practice, speeding up the development of new treatments, and allowing for personalized medicine. With its ability to improve patient outcomes and save lives, translational medicine is a powerful tool for transforming healthcare, and one that will continue to play an important role in the future of medicine.
References
- Rocci Jr ML. The american society for clinical pharmacology and therapeutics (ascpt)?a rich heritage en route to an exciting future. Clin Transl Sci. 2016;9(1):6.
- Wang X. A new vision of definition, commentary, and understanding in clinical and translational medicine. Clin Transl Sci. 2012;1(1):5.
- Rubio DM, Schoenbaum EE, Lee LS, et al. Defining translational research: Implications for training. Acad Med J Assoc Am Med Coll. 2010;85(3):470.
- Li CH, Bies RR, Wang Y, et al. Comparative effects of CT imaging measurement on RECIST end points and tumor growth kinetics modeling. Clin Transl Sci. 2016;9(1):43-50.
- Ehmann F, Caneva L, Papaluca M. European medicines agency initiatives and perspectives on pharmacogenomics. Br J Clin Pharmacol. 2014;77(4):612-7.